Viewing Study NCT01711658


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-02-19 @ 5:48 PM
Study NCT ID: NCT01711658
Status: COMPLETED
Last Update Posted: 2023-10-17
First Post: 2012-10-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
Sponsor: Radiation Therapy Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: RF-3501
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View